Press release
Preimplantation Genetic Testing Market worth $1.2 billion by 2028 | Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US)
Preimplantation Genetic Testing Market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $1.2 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the high risk of chromosomal abnormalities with advancing maternal age, and the rising number of fertility clinics. Furthermore, the use of fertility treatment options by single parents and same-sex couples is expected to drive the growth of the preimplantation genetic testing market.Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=605&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
The preimplantation genetic screening segment is expected to account for the largest share in 2022.
Preimplantation genetic screening, or aneuploidy screening, involves screening embryos for the assessment of aneuploidy. This segment is expected to dominate the global preimplantation genetic testing market during the forecast period, driven by a decrease in female fertility with rising maternal age, better implantation rate and reduced IVF cycle times.
The fertility clinics segment held the largest market share in the preimplantation genetic testing market.
By end user, the global preimplantation genetic testing market is broadly segmented into hospitals, diagnostic labs, fertility clinics, and other end users. The large share of this segment can be attributed to factors such as the increasing number of fertility centers globally, the high success rate of treatment in fertility centers, and growing medical tourism in developing countries.
North America dominates the global preimplantation genetic testing market.
Based on the region, the preimplantation genetic testing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American market is driven by high incidence of chromosomal disorders, and an increasing number of awareness programs. Europe is the second-largest market for the preimplantation genetic testing market due to the low fertility rates and increasing maternal age in the region. Asia Pacific will observe high growth during the forecast period with its growing medical tourism for infertility treatment in the region's countries.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=605&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Preimplantation Genetic Testing Market Dynamics:
Drivers:
Declining fertility rate
Restraints:
Alternative therapies and medications
Opportunities:
Use of fertility treatment options by single parents and same-sex couples
Challenge:
Socioethical concerns surrounding preimplantation genetic testing
Key Market Players of Antibody Drug Conjugates Industry:
Major players in the preimplantation genetic testing market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Revvity (US), and The Cooper Companies, Inc. (US).
Recent Developments:
In 2023, Thermo Fisher Scientific Inc. (US) launched two new NGS-based test kits to support preimplantation genetic testing-aneuploidy (PGT-A), commonly used in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=605&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preimplantation Genetic Testing Market worth $1.2 billion by 2028 | Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US) here
News-ID: 3380609 • Views: …
More Releases from MarketsandMarkets

Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your R …
The global laser interferometer market is expected to be valued at 315 million in 2024 and is projected to reach USD 447 million by 2029, at a CAGR of 7.2% from 2024 to 2029. Emerging applications in industries push the market's growth due to the growing demand for precision in the manufacturing sector. However, challenges such as higher initial investments and maintenance costs cause problems. Despite these, opportunities arise for…

With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to …
The battery testing, inspection, and certification market is projected to reach USD 36.7 billion by 2029 from USD 14.9 billion in 2024 at a CAGR of 19.6% during the forecast period. Increasing adoption of EVs and energy storage systems, rising enforcement of stringent standards to ensure battery safety, thriving portable electronics industry, and rapid advances in battery technology are the major factors contributing to the market growth.
Download PDF Brochure @…

Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMar …
The global RTLS market for healthcare is projected to grow from USD 2.3 billion in 2024 to USD 5.7 billion by 2029, at a compound annual growth rate of 19.6% from 2024 to 2029. As it attracts more and more players who enter this market with innovative RTLS features for customers, the market for RTLS technology is rapidly increasing. Top companies in this market focus on healthcare, retail, and manufacturing…

Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2 …
According to a research report "Offsite Data Center Power Infrastructure Market by Component (Solutions and Services), Vertical (BFSI, Media & Entertainment, Government & Defence, Healthcare, Manufacturing, IT & Telecom, Retail) and Region - Global Forecast to 2030" published by MarketsandMarkets, the market size for global offsite data center power infrastructure market is projected to reach approximately USD 35.4 billion by the year 2030, as compared to the estimated value of…
More Releases for Preimplantation
Preimplantation Genetic Testing Market Scope & Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Preimplantation Genetic Testing Market size was valued at USD 467.52 Million in 2020 and is projected to reach USD 995.76 Million by 2028, growing at a CAGR of 10.01% from 2021 to 2028.
The growth of the Preimplantation Genetic Testing (PGT) market is driven by several key factors. The increasing prevalence of genetic disorders and chromosomal abnormalities has significantly heightened the demand for advanced diagnostic techniques such as…
Preimplantation Genetic Testing Market worth $1.2 billion by 2028
Preimplantation Genetic Testing Market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $1.2 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the high risk of chromosomal abnormalities with advancing maternal age, and the rising number of fertility clinics. Furthermore,…
Preimplantation Genetic Testing Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Preimplantation Genetic Testing (PGT) (PGS/PGD) Market will expand with a CAGR value of 6.2 percent from 2021 to 2026. Because of the growing incidence of genetic, inherited, and chromosomal disorders, the global PGT industry is projected to expand significantly during the projected timeline.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-preimplantation-genetic-testing-pgt-market-3112
By PGD/PGS (Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS)), By Type (Chromosomal Abnormalities, X-linked…
Preimplantation Genetic Diagnosis Market| Key Players - Genesis Genetics, Genea …
As per the current market trends and the promising nature of the Preimplantation Genetic Diagnosis market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Market Research Reports Search Engine would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode various…
Preimplantation Genetic Diagnosis Market Opportunity Analysis, 2018-2026
Preimplantation genetic diagnosis (PGD) is the genetic profiling of the pre implantable embryos and oocytes before their implantation. The preimplantation genetic diagnosis is similar to that of the parental diagnosis in case of screening for a particular genetic disease. The PGD is advantageous in a way that it helps to avoid the selective pregnancy termination by development and growth of healthy fetus. PGD serves as an addendum to assisted reproductive…
Global Preimplantation Genetic Diagnosis Sales Market Report 2021
Global Preimplantation Genetic Diagnosis Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The report provides a holistic overview of the global Preimplantation Genetic Diagnosis market. It studies the market’s trajectory between 2016 and 2021. Compiling various factors encouraging the market and relevant data summarizing the market’s trajectory in the past few years, the report makes for a guidebook for…